揭示了由酸暴露引起的骨髓毒性的机制
1College of Animal Science, Anhui Science and Technology University, Fengyang, 233100, China.
Biological trace element research
|June 28, 2023
概括
暴露于会通过不清楚的机制引起骨髓毒性. 这项研究确定了PLD2和TNF等关键基因,这些基因与酸诱导的骨髓毒性有关,为分子途径提供了洞察力.
科学领域:
- 环境毒理学环境毒理学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- (Pb) 是一种普遍存在的重金属,已知会在包括骨髓在内的各种器官中引起显著的毒性.
- 导致引起的骨髓毒性背后的精确分子机制在很大程度上仍未被阐明.
- 了解这些机制对于开发有效的干预措施和减轻与暴露相关的健康风险至关重要.
研究的目的:
- 为了确定关键的枢纽基因涉及的骨髓毒性由酸 (PbAc2) 暴露引起.
- 阐明受暴露在骨髓中影响的分子通路和生物过程.
- 为了解引起的血毒性病原发生提供基础.
主要方法:
- 利用基因表达综合 (GEO) 数据集GSE59894,比较酸治疗和对照组的骨髓样本.
- 采用差异性基因表达分析,以确定PbAc2.2在不同时间点 (1日和3日) 和剂量 (200和600毫克/公斤) 的显著基因变化.
- 对重叠的差异表达基因 (DEGs) 进行生物过程和途径分析,以发现受影响的分子功能和信号级联.
主要成果:
- 在PbAc2治疗后的早期 (1日) 和晚期 (3日) 时间点中确定了大量的DEG.
- 叠加的DEG在生物过程中显著丰富,例如细胞分化和对外来生物刺激的反应.
- 路径分析显示了关键信号路径的参与,包括PI3K-Akt,TGF-β,MAPK和骨质细胞分化.
- 确定了潜在的枢纽基因,包括PLD2,DAPK1,ALB,TNF,FOS,CDKN1A和TGFB3,作为PbAc2诱导的骨髓毒性的关键参与者.
结论:
- 该研究成功地确定了关键基因和参与诱导骨髓毒性的途径.
- 这些发现强调了细胞分化,药物反应和特定信号通路在对骨髓的毒性影响中的作用.
- 已识别的枢纽基因为未来对中毒分子机制和治疗策略的研究提供了潜在的目标.
相关概念视频
Toxic Reactions: Overview
1.0K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
The Periodic Table and Organismal Elements
180.2K
Overview
180.2K
Bone Marrow Sampling and Transplants
363
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363


